This two-day event will feature luminaries and thought-leaders as well
as the voices of those impacted most by the NBCCEDP.
Two days of thought leadership & peer engagement
Engage with CDC breast and cervical cancer screening award recipients and partners to build upon cancer screening processes from the last 30 years,
accelerate efforts to improve screening outcomes in the future, and close gaps that persist in some groups.
CDC awardees, partners, and other public health professionals are invited to attend our virtual event and celebration.
Cancer is a disease that can affect anyone,
but it does not affect everyone equally.
Black women have the highest death rate from breast cancer, and among Latinx women, breast cancer is the number one cause of cancer
deaths. Although cervical cancer incidence and mortality is declining overall, rates are considerably higher among Latinx and Black women.
Working together we can help save lives through early screening and detection, leading to effective treatment decisions.
Saving Lives through Early Detection of Breast and Cervical Cancer
According to the most recent U.S. Cancer Statistics report (2018) more than a quarter-million women were newly diagnosed with breast cancer, and more than 42,000 died from the disease. While the rate of deaths from breast cancer has decreased since 2004, it is the second-most common causer of cancer deaths in U.S. women. Cervical cancer once was the leading cause of death for women in the U.S. During the past five decades, incidence and mortality from cervical cancer have declined significantly due to the widespread use of the Papanicolaou (Pap) test to detect cervical abnormalities. Despite the decline, in 2018, more than 12,000 women were diagnosed with new cases of cervical cancer, and more than 4,000 women died from this preventable disease.
What They’re Saying
#EarlyDetection
Copyright © 2021, National Breast and Cervical Cancer Early Detection Program.